DVAX vs FFIV · rev $277.2M vs P/E 32, rev $3.09B
Dynavax Technologies Corporation (DVAX) versus F5 Networks Inc (FFIV) — a side-by-side from cached financials, not a winner call.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
DVAX currently screens at market cap $1.82B. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
Not investment advice. Open the DVAX and FFIV stock pages for the full models.
Not investment advice.